Wacker Chemie AG (WCH) Earnings Call Transcript & Summary

September 17, 2026

XTRA DE Materials Chemicals investor_day 103 min

Earnings Call Speaker Segments

Tobias Ohler

executive
#1

Thank you, Chris. Hello, everyone. I will present to you the actions we are taking on structure and bases. Our priority here is straightforward, make Wacker leaner, faster and more efficient. Obviously, over time, as time goes, complexity has increased with growth, new businesses and expanding global operations, refocus addresses this by streamlining structures, reorganizing processes and improving accountability. A key element is our past cost and efficiency program. The program is on track with Q4 last year. And in Q1 this year, we already started with the implementation of FirstMerit, especially nonpersonnel measures, and for the organizational restructuring, we moved here step by step, and we started in Q3 2026 and expect to have all the restructuring done completed by the end of 2027. The teams spread over 8 distinct work streams are working really hard and with great help implementing all the fine items and all measures are to be completed in '28. PACE targets, both nonpersonnel and personnel costs. As things move faster on the nonpersonnel side, the first visible savings are already being delivered. We reduced expenditures through lower technical spending, structural savings and procurement and tighter budgets, and we are controlling and monitoring that will be very tightly on a monthly basis. For personnel costs, benefits will begin to materialize from '27 onwards. In the second quarter of this year, we reached an agreement with the works council in Germany to reduce around 1,600 positions. This is truly a milestone achievement and that's the time line for a stringent implementation going forward. Paste makes Wacker, leaner, faster and more efficient. Therefore, a [indiscernible] of pace is simplifying how we operate and just an example. We are merging operating into larger functional units and centralizing support teams to improve efficiency and accountability. Another example, we are reorganizing our entire engineering processes to align around 44 departments with clear roles and responsibilities and integrated functions. The goal is not just to have fewer organizational boxes. The goal is faster execution, better performance and stronger accountability. And PACE is on track. In 2026, we will achieve around EUR 200 million in savings and gross savings, of which EUR 85 million were already saved in the first half. That means for the second half, there are EUR 115 million to save. Annual gross savings will expand to more than EUR 300 million in 2028, and as we stated before, more than 50% will remain EBITDA relevant as net savings after accounting for inflation. The structural impact of PACE is important. It lowers our breakeven point and increases again resilience of the company. This creates an additional leeway to invest in innovation, technology and attractive markets. PACE is not just about cost cutting. It's making Wacker leaner, faster and more efficient and such laser foundation for focused growth. And be on pace, there is obviously much more. Our advanced digital foundation enables AI scaling for greater impact. Over the past couple of years, we have built a strong digital foundation. Just as a highlight, Wacker has just 1 single ERP, and we are running on [indiscernible] our digital organization has been established and is up and operating. Gen AI tools and data layers have been implemented. And all this was a big effort and now we can scale up for greater impact by implementing AI capabilities across Wacker. This is a fascinating do to me per and definitely for the company as a whole. And with this, back to Chris.

Christian Hartel

executive
#2

Thanks, Tobias. While actions taken on structure and processes help us to become leaner and faster and more efficient, they are only 1 part of refocus. But they are integral and important part of the process and also worth to mention, they are real. The PACE savings are real and they work. Another priority is to elevate our business model and value proposition. So now let's talk about another important ingredient of success talk about growth. We are coming from an environment defined by broad-based growth, especially when I look back at our 2022 CMD here at TATE. Today, the environment is clearly different, and not all the opportunities offer the same potential. That is why we are implementing a new work for portfolio management with differentiated steering. We will become more selective, much more selective about where we invest, where we innovate and also where we allocate our resources. Now how does the playbook look like? We have implemented 4 different portfolio roads to steer each business. Now let me briefly go through these categories, accelerate growth businesses, they have substantial upside with high innovation potential and value-based pricing for very attractive margins. [indiscernible] we are focused on leveraging our established market positions to generate resilient cash flow. And turnaround is about 5% of sales. Here, targeted actions are required to unlock the future potential. If transformation is successful, they will move to accelerate growth and would receive additional resources. Now let's have a look at -- closer look at Accelerate growth, and you can see here some of these fast-growing end markets on the slide. Our portfolio approach means more focused innovation. We had direct resources towards markets with strong structural demand growth that aligns with our strength. You see a lot of good examples here, and we let me focus on the hypersonics AI and high-end chips are driving demand for powerful and densely packaged semiconductor devices. So they run hot. They require advanced thermal management and we partner with customers to solve these critical challenges. Our thermal interface material is improve the heat transfer, the long-term reliability and the energy efficiency. And with the massive investments in data centers, we expect to see continued structural demand growth in these applications. As you can see, there are many examples of backer solution, which we introduced recently. Now let's have a look at the optimized return category. Again, not at good exact here. But let's focus on the ultra-ultrahigh pure polysilicon. We are the leader in our material is critical for the highest-performing semiconductor. The market is for strong long-term growth, and we have just expanded our hedging capacity for the highest quality Therefore, our focus is on operational excellence, on yield improvement and on cost. This strengthened profitability while reinforcing our technology and market leadership. As you can see, optimized return has very attractive businesses where we can undervalue without major new investments. The VAE powder of power sales [indiscernible]. Our segment's strategies reflect individual portfolio growth. Now starting with Silicon. We provide a right range of products from upstream standards to bespoke high-end specialty solutions. In Silicon, 17 out of these 25 units, you can find -- some of the most attractive growth opportunities also allocated in this segment. We are well positioned with our expanded debt base, which I mentioned before with the recent additions in downstream capabilities. So we will drive selective asset light, downstream expansion to capture opportunities in fast-growing markets. Polymers, on the other hand, are less complex. As you know, we serve the adhesion and coatings market from a shorter value chain, dispersion powder [indiscernible] so just 3 portfolio units. The latter 2, powders and resins, higher differentiation potential, stronger profitability and returns by our cost by capital discipline. BioSolutions has 3 portfolio units. Biopharma, bioingredients and Life Science Chemicals. Today, we are focused on commercial excellence to exploit the full potential of cutting-edge biocide. At Polysilicon, last but not least, have 2 portfolio units. Our focus is on semi, and we will expand our same leadership while maintaining the U.S. solar option for the time being. And in each segment, we are pursuing specific priorities. So different actions, but 1 common objectives are not the full potential. The next 3 focused priorities excelling with our people and our culture. And that's often a miss, I would say, but it's integral part if you want to proceed in our executing the strategy. The success of implementing our portfolio roles ultimately depends on our teams. So it's about having the right capabilities, leadership and culture throughout the organization. And as our business models evolve, the skills required to also evolve. That's why we're investing in our people and make sure that we have a long-term winning teams. So different portfolio roles, obviously also train capabilities. Now for the accelerated growth, we need teams with proactive business hunting mindset, coupled with disciplined execution to drive faster commercialization. For optimize return, we need rigorous performance and efficiency management skills to improve margins and return on capital. For maximize cash, you again need a different mindset. We need to embed cash and cost culture as a daily management position. So you don't talk so much about growth in that category. But you talk about how can you increase the cash generation. And for turnaround, finally, we need range relationships with key customers and follow strict milestones to process to real growth. So my responsibility instead of the entire board to ensure that each team has what it needs to succeed in their specific mission. We've already launched a program to build long-term winning teams. The one [indiscernible] promotes collaboration across functions, businesses and geographies and essentially fibers teams. Leading at Wacker has strengthened the leadership capabilities throughout the organization and at the same time, we are investing in AI and digital skills to prepare our workforce for the future. Together, all these initiatives help build the culture and capabilities needed to deliver refocus successfully. So let me briefly summarize before I hand over to Tobias. We have taken bold steps to a more and much more challenging market environment. We have a comprehensive program running. We have defined a holistic approach where the strategic priorities for structure and processes, business and value position and people and culture. And we have implemented and we are running, the cost and efficiency program pace, and we are on track to save EUR 300 million annually. Building on our success in pace, now Ignite if you want the next level of selective growth with a new playbook for port management and differentiated steering. Importantly, we see distinct value creation potential across all 4 segments. With clear portfolio roles anchored in the organization, we will drive the spirit and the commercial success. Together, these actions are creating a leaner a more efficient organization, which will strengthen our long-term competitiveness. We are absolutely confident that we focus will unlock our full potential within our 3 strategic priorities. It's the foundation of new financial entity year. Tobias?

Tobias Ohler

executive
#3

Thanks, Chris. Let me briefly outline what I will cover over the next few slides. First, I will review our performance and how we maintain solid financials and improve resilience side all the headwinds. I would then show how we focus drives our ambitions for growth, profitability and ROCE and obviously also touch on current trading and order with probably government where we intend to go. The last several years have been defined by excess market volatility. Post-COVID gave way the headwinds across many customer end markets. And despite this, our chemical specialties businesses continued to grow and expanded our global leadership positions. In Polysilicon, we have seen strong semi demand growth, and we grew double digit from peer, which was above market. Unfortunately, this development is not visible at first look, as these wins are being offset by solar beer volumes have contracted due to overcapacities in China. BioSolutions, our new [indiscernible] Competence Center, which is part of the German [indiscernible] preparedness program strengthened our position in advanced [indiscernible] back to Chris' comment about products that we had shown at the last CMD in Wacker in the [indiscernible]. We talked about our new hedging line. We talked about the silicon hybrid polymers plant our new mRNA competence center as well as about our electronics and health care silicon specialties. These businesses taken together now generates more than EUR 500 million more sales than a few years ago. So we have achieved strong growth in some focus areas and our recent investments are the foundations for future growth. Despite the headwinds and the high investment period, we maintained solid financials around for key balance sheet items. First, we increased our already strong liquidity position that was clearly reported by cash flow generation and disciplined working capital agents. Second, we kept financial debt low. This year, it comes in around EUR 100 million at the end of the year, which equates to a comfortable leverage level of below 1x EBITDA. Third, and almost forgotten, we reduced the pension deficit, a big topic a few years ago by modernizing our [indiscernible] system. We also into use the capital option. But we also did voluntary top-up and we funded through a CPA, the unfunded portion of the liabilities with more than EUR 250 million -- EUR 250 million PTA, which likely over the last for with the Stockholm. Higher in count rates were also supportive. We increased overall shareholder [indiscernible] EUR 4.2 billion despite returning EUR 1.5 billion dividends to shareholders during that period. Our solid foundation is a basis for everything we do and it allows us to invest in selective growth while navigating also under the market. So now looking forward, our ambition is clear. structural EBITDA margin of 15%, plus/minus 2 percentage points. We have delivered this performance before. However, our performance has fallen short of this over the past couple of years. That is why we are taking decisive both actions through refocus. We will achieve our margin ambition by calling never first, drive growth. We will focus our resources to drive selective specialties growth. And we will leverage our existing assets and expertise into commercial success. Second, as cost, we will deliver annual paid cost savings of more than EUR 300 million in 2028 of which more than 50% will be retained in EBITDA. And as we talked about, we will invest in cash and cost culture as part of some portfolio units to maximize cash. Third, improved resilience. We will protect margins with our focused pricing playbook to optimize returns. This is so important to can take volatile and dynamic market environment. And taken together, these actions will allow to consistently deliver on our structural margin and et side -- for the more we that our ambition is that regardless of which scenario plays out which system. Refocus changes how we prioritize capital allocation. Over the recent years, we have invested our global footprint, and we have invested in capabilities. That investment phase is now behind us. Those assets provide a strong foundation for future growth. Going forward, our priority is to leverage existing assets and expertise to drive commercial success. We will keep our CapEx below depreciation and in edge EUR 300 million to EUR 400 million, of which maintenance is some EUR 200 million. Despite lower investments, we will accelerate growth by focal resources on the most effective opportunity. Our ambition is to gain ROC back to more than 10% as net cost growth, get it back to more than 10%. That means above our cost of capital. We have shown this in the past but recent performance has been well below that. The combination of progressive and margin decline led to insufficient capital returns. And there are 3 main levers to get us back on track. First, raise EBITDA through growth and cost cutting, obviously; second, strict capital discipline with a focus on leveraging our existing efforts and third, optimize and continue to optimize working capital management. Together, these actions will drive the nominator and the denominator down to achieve a rose to changes lead at last and time. Going forward location priorities are clear. Growth and maintenance of business, #1. #2, to maintain the financials. #3, will make, as we said, selective growth investments while maintaining assets to insurance sales and reliable operations. At the same time, we will leverage our already existing assets and expertise to drive commercial success. Our driven policy is unchanged. We aim to distribute roughly 50% of net income. That's number three, maintain solid financials with a financial leverage target of 1x EBITDA, also allowing for some flexibility. Putting it all together, our capital allocation part to reflect our well-balanced approach to selected growth, shareholder return and financial results. Sustainability remains in several part of our strategy. Going forward, we will realize selective growth opportunities, and we will remain on our pathway to net row by 2014. Our target is to reduce our footprint and strengthen partnerships with the customers. Our pathway to Net Zero, there are 3 principles to it. Number 1 is green silicon, number 2 is process transformation, and number three, a switch to renewable energy. For us, sustainable sustainability is an investment and it should also be a good bits. In our last earnings call, we highlighted that Baker recently received L'Oreal's Energy Award in the raw materials category. By reducing CO2 emissions from silicon metal production in Norway, we reduced our financial risk and create opportunities to grow with strategic customers. So that part shows how sustainability and innovation go and Refocus is a holistic approach to go, how we operate, how we compete and how we create value. We have defined clear strategic priorities to be. And these 3 priorities we complement each other. Together, they will unlock our full potential are the foundation for our financial position. on this slide, we also drive GDP plus growth by making selective growth investments and improving mix. We aim to raise our structural EBITDA margin to 15% plus/minus 2 percentage points by delivering on our growth on our cost and efficiency program. And number three, we aim to get ROCE back as soon as possible is up 10% in terms of our cost of capital. So these 3 targets, ambitions drives all that we have in our refocus setup basically on self-help by the company. Before I hand you back to Chris, let me address trading. Our strong performance continued in the third quarter. Group EBITDA will likely be at the same level as in the second quarter. Chemicals see stable to slightly better EBITDA performance. Biosolutions roughly similar to the prior quarter. Polysilicon will be approximately EBITDA in the quarter, including a special income of approximately EUR 3 billion from the solar contract resolution. But operational and polysilicon performance is held back by a disappointing 2-3-2 decision. Despite this, if you look at the 3 quarters, the group earnings are up driven by execution pace, pricing actions and strong operational performance have delivered tangible results year-over-year and with this, I will pass to Chris.

Christian Hartel

executive
#4

Thank you, Tobias. Next step for Wacker is refocus. Refocus, as you said, it's a holistic approach to improve how we operate, how we compete and how we create value. Refocus is built on our 3 strategic priorities that reinforce one another. Our business priorities are clear. It's about profitability. It's our ROCE and it's for selected growth in the tract market, and we have a clear plan for refocus. The new playbook for portfolio management as defeating has been defined and in and is now ready for execution. Past cost savings are full swing in execution. For the next 3 years, our agenda is set. In Polysilicon, we will lead the way in the next generation of semiconductors and optimize our performance by focusing on automation, technology and yield improvement. In BioSolutions, we will leverage our cutting-edge technologies and focus on commercial excellence and customer partnerships to fill our assets. For polymers, we will leverage our unmatched footprint and leading application expertise and optimize to improve margins and return on capital. And it will leverage our own excellence centers close to customers to our selective growth. Before we discuss [indiscernible] leave you with one key message. Wacker enters this next phase from a position of strength. We have leading technologies, we have strong market positions, and we have high-quality assets, built 3 years of targeted investment. The focus is now on execution. -- through refocus, we are concentrating on the opportunities that are within our control to improve profitability, increase returns and accelerate value creation. And we are confident that it will unlock upside in earnings and strengthen buckets competitiveness for the long term. So thank you for the attention. And Tobias and I are happy now to take your questions and comments. Thank you.

Unknown Attendee

attendee
#5

Technical issues with the Internet [indiscernible] land line solution. So we want to do, we have the question. I'll give you my mobile for the question, and then I'll run back and forth. You probably didn't notice it. So who would like to have the first question. [Operator Instructions].

Unknown Analyst

analyst
#6

-I'm Katie [indiscernible] from Barclays and asking on behalf of the covering analyst, Anil Shenoy. You talked to your Wacker polysilicon. We'd just be interested to get your talking through the upside in both of those areas. What do you think the EBITDA potential could be in a successful Section 232 environment? And you also spoke about closing down the U.S. sites, what kind of savings do you think we've achieved from this?

Christian Hartel

executive
#7

Okay. Yes, as I mentioned before, if actually we do what the aim to revitalize the U.S. market for solar and on silicon and in its current reading, it does not provide the support which is which is a deposit Yes, we keep engaged in very constructive to with the U.S. government, and we found on the ongoing commitment the government to support domestic poly production in the U.S. So therefore, it is too early to speculate what will be the outcome of this you say more at the moment. But I may be testament on the either scenario is that none, which would be presented 1 or the semi-only scenarios we see better than the situation of uncertainty that we have today. The same you mentioned, yes, there will be structural gross in trading the early to us because it's still open.

Tristan Lamotte

analyst
#8

Tristan Lamotte from Deutsche Bank. I just wanted to go a little bit further on that question around Section 232. But what specifically is it in Section 232 that is not incentivizing the behavior that you expected. Is it specifically the lack of protection around U.S. Polysilicon? Or what are the kind of clauses that you look at and you think maybe that could be tweaked to make it a little bit more beneficial and had the effect that it was intended to have?

Christian Hartel

executive
#9

At the current reading definitely incentivize the use of domestic U.S.-made Polysilicon, just leaves something for import pricing. But as you also know, there's not a big import of Polysilicon actually going into the U.S. right now. Therefore, this concept with the minimum input price itself is not incentivized in the use of U.S. made Polysilicon silicon. And therefore, we keep on talks with the U.S. government.

Unknown Analyst

analyst
#10

Two questions, please. First of all, on [indiscernible] [Technical Difficulty] your rating phase for seasonally 1 of your biggest properties that action. So we have and will the last month for the year. Next, on your solution segment. It's a very broad portfolio for a very small technique to segment contracts. Can you give us are product lines for condoning business.

Christian Hartel

executive
#11

[indiscernible] give you an update for Q3 and you're asking for Q4. You're very good. So let me start with some details on Q3. So as I said, chemicals have performed nicely. We have seen summer dip in August, but September, there is a good order pattern that might also be a dedication on how to look at Q4 by solution move sideways, then they can obviously had the disappointing to effect we talked about, and I think we can't talk much more about it. I mean there's no good solar demand from the ruling, obviously. But I mean, looking for the -- I mean, to the full year, obviously, after 3 quarters, -- and on third quarter left, we see us more in the upper half of the guidance range. So we expect typical seasonality in chemicals and see that there's no, yes, positive effect on solar. So from that perspective, that should give you a little bit of a of an idea how we see Q4. I can only agree to that. We don't see a positive spend from the market. Our performance, especially in the Polymers division is managing the volatility. As we described, we have a pricing playbook in place, but we have ups and downs in the raw materials just on a weekly basis depending on what happens in the Middle East. And our teams are really managing moving through that in a very bad way. But there's no end market demand uptick growth in the polymers division.

Tobias Ohler

executive
#12

You add to this in the bottom was portion area. What we see now is that in many areas, the aspect of supply security becomes more important for customers. And I would say also traditionally more conservative reasons like let Europe versus Asia. So -- and that's another lever which we now see and can do also in respect to the pricing pay. You have a question on the Solutions business. So they have 3 business units. I wouldn't rather call them too complex because all of them -- I mean, the bioflur very much faced on hydro CDMO activities and RNA ingredients selective ingredients by fermentation. So we see it as a very clear portfolio unit here. All of these units also the Lifescience Chemicals contribute today -- and the 2 of them are, let's call it, turnarounds, which means we believe in the underlying growth that is reachable in these segments. And therefore, we have a very clear milestone plan to turn it around and to move into accelerated now. So from today's perspective, there's no more point in questioning that, but the teams have to deliver on undivided goals for the next 2 years.

Unknown Analyst

analyst
#13

[indiscernible] JPMorgan. I have a few questions. I'll ask with the top ones. You mentioned this refocused ambition, what is the time frame to it. [indiscernible] that time frame. Second, just coming back to the policy question, please that we see the back -- it seems like the whole strategy...

Christian Hartel

executive
#14

Strategy on solar is just based on hope. And I mean at what point do we go from that pace to just taking action because when your Q3, you're actually losing customers because that's why you got that special income, when we thought you should be gaining customers. So how do anybody get us concur that a turnaround in this business is even possible. And in your scenario of setting or taking cost actions -- and I asked this question so I don't know if you have a bit in terms of what impact does it have on your [indiscernible]. All of this at a rate typically in 1 time. So how even related to the switch off for the solar without [indiscernible].

Tobias Ohler

executive
#15

I'll start with a question on the time frame in the repo women we have it on website at is 268 the refocus above action. And our ambition, obviously, is to get these at the end of the year time frame to the corridor. And -- but we're not giving guidance now for '26, '27 and 2028 for the fiscal year. Refocus is about satellite growth, and we mentioned that we can pursue tractive markets work with innovation even in a changing environment. So we have delivered also as we assume the growth session last year on those projects, we really can grow. As we deliver on the pain of savings and power. And that should bring us into that port. And obviously, we do a if you reach 15% and if you take depreciation at the employee and their capital on slow over time because of the lower investment depreciation will have added some working capital. But in terms of the denomination go down. So if we reach the 15%. We will also rapidly start of that term that in the speech, we want to get there as quickly as possible but there is no guidance [indiscernible].

Christian Hartel

executive
#16

But I would not say that our strategy for our ports at all. It's based on opportunities. It is a rise from [indiscernible] so is the greatest thing that -- so we need to look for opportunities for the company and shutting something down on an excel opportunity this production plan. So therefore, we thought then yes, I would open have a better outcome already. So I would have lost out already a year ago. But we talked about polite world. It is more specifically than. So we are in the situation we are now because we still see that opportunity. And we keep on tracking for our opportunities. I think it would not divide now a decision before a private ruling is now say, I'm set up and we get out of everything. And it is old. So we keep that opportunity and we work on it. And if there is here clarity and certainty at what there's clear uncertainty, you can be sure that you will take the action. And so it's not so we don't want to be division. It is more about because they're still in the morat which we could pursue. Second part of your question was on the integrated site scenario as a public scenario that would not need to set up that we have today. Today, we can introduce at all our sites semiconductor of silicon. And Again, it has to rely decide what to do because it is far ruling on 2, but because essentially all the sites for semiconductor [indiscernible] a lot of positive outcome for the incentive for protection of volatile than to a position now. And yes, on the integrated side, it is our [indiscernible].

Unknown Analyst

analyst
#17

Three questions from my side. I think you mentioned that the maximizing cash activity or accounting roughly 4 and we said it currently. I wonder whether you can shed a bit more light on the other part of it looks like these days? Second question is on your -- one of the ports was about focus pricing achievement which you want to use the can you give us a bit more color on where you think you are payable in the environmental focus achieved. And the third one is to the tax to precede December basically the implementation date. We reached that by December, there is no basically entrance in play, which is union that we may hear more about the topic on the I think the last question. As much as I would love to say yes I don't know what [indiscernible] it won't be on a I think that's helpful -- your question on the port units, the accelerate growth is around 10% to 15%. The optimized return is also similar to the maximized cash around 40% and 50% will be the remaining. Question on the pricing actions, I think, the key success [indiscernible] action is that you have a table, which is based on different customer segments and regional. Of course, we see a very extent difference in talking to customers in the construction forces in Europe. And therefore, the either needs also their needs regarding supply security. We also have to make a kind of ipackage which helps on the past. And also in China, the speed of reaction much faster for the customer lotion and the raw material goes up today for the crude oil. And they call you today because tomorrow prices will be higher. [indiscernible] actual group for longer term more on a weekly basis. And I think the best thing we can react to what the customer was its needs are better but also integrated that's 3 questions. First, on price books. You talked about focusing on the mono accident, I could explain a little bit what the impact -- and then also I hope you think about salmon were contributed to the other parents going forward and a little bit of overtime that we -- and second is for the selling business in foil all many of the competitors lean China development. And then [indiscernible]?

Christian Hartel

executive
#18

Okay. So we also the [indiscernible]. I think it's a very good pricing level. And part of our strategy we want to reduce our stake in dustproof time. We have no Russia and we wait for the right 1 retrospective, I would say maybe global look at on to set down and we compare to further steps in the future. We see that the market is attractive for us. On the and let Well, let me put it this way. I think when we did also the acquisition in the field of Biopharma, especially they've got very strong focus coming in by on technology for the new applications. And are we prepared -- do we have the right technologies in place. And maybe there were not so much focus on the how to gain new projects, be more aggressive biting for projects maybe a little bit too negative [indiscernible], I would call it. And that's what [indiscernible] change or people in the team. We hired external people with a lot of expertise and obviously, as I said, the market also more challenging. I still believe very much in the opportunities in announcement. So there's a lot of opportunities coming up, it is slower than expected as many times. So therefore, I think it's all important in our focus the 100% loss on commercial execution and commercial [indiscernible] all of our segments will contribute to our financial ambitions and thanks for [indiscernible] growth. So I think when you look back in the last 2 years, we had double-digit growth in semi. And I think pro also think as the market was for growing the high single digit signal. And having share about 5% and then Ingoing the market for, so I think was rather accomplishment. So going forward, I would still say there is growth in the Semiconductors factors into high single-digit number, which would also be the target about a you go to market [indiscernible] but we will go with a single mid-single to high single-digit number for the next year. But also, don't forget that every year will be the same. It's always a straight line. But overall, the next years, we. I don't expect every year to be up the last. Well, I think the actually that is bad [indiscernible] in the market with a big with it and log -- we're working on their all the urea pretty much, I would say, on what's going on to them. I think we have a good position also here. So a big question about both [indiscernible] and we see that, which I need that [indiscernible] is branding shares in China, which is also part of the 5-year plan. and part of the political agenda. That's probably the biggest going forward. Another question -- they will have -- I have a share in China, question how much we need outside in China. And so far come from customers or dependent on Chinese material saving something [indiscernible] follow-up as again questions. Let's not be remind us because now we are going to see a sound reduction per the to cash flow for it. Can you mind as how much of the cash cost to implement all the pro reductions? And just pricing part, -- on power price, in fact, that we see gas and power prices in Germany but Florida. Remind us your hedging and how you're thinking about the potential impact much more than [indiscernible].

Tobias Ohler

executive
#19

So on hedging, is super qualified as we see out of [indiscernible] crude and gas prices have followed. Our hedging model is rolling, and we have secured a large more than 80% for -- also for the winter season, then the remaining [indiscernible] but we also need to see whether those prices are daily for the winter season was prepaid or whether, yes, we could have a release in the windy winter and then I mean at price are completely different to what you could buy today. But our hedging in policy going forward is always to smoothen out the peak, and we are roughly 85% net for Q4 and Q1. Your first question was on PACE. So that we are well on track. So the run rate for savings for the second half is higher on the personnel measures are now kicking in, but the majority or more will up over time, 2016 and 2018 forward. But assume with the agreement with the west council, there were no force for the voluntary program. So we've moved out and never the attrition plus extradition yes, people leaving with severance pay. So we had accrued EUR 100 million in last year for all the measures. And if you think about the cash out part of that cash out will be also need to support early retirement so that we having that cash out that we have funded with the accrual and for those leaving immediately is still in 2026. I mean the cash out would be relevant. But not a precise number, I would assume it to be less than EUR 60 trillion been cash relevant.

Unknown Analyst

analyst
#20

[indiscernible] from Deutsche Bank again. Just a few more. First 1 is, I'm just wondering a little bit about chemicals demand and your views? Like if you kind of take a step back, why do you think the demand has held up so well this year in a tough environment? And then maybe second, because of the exceptional that you alluded to in Q3 in polysilicon, you're kind of implying a EUR 10 million run rate. Is that kind of a real run rate? Or is it a run rate that isn't a real run rate that we should extrapolate? I appreciate that might be difficult to answer. And then maybe to kind of high level, do you think you can grow in polymers and silicones next year?

Christian Hartel

executive
#21

I would say, I mean, if there is no catastrophe and codes coming, which nobody has on his line today, could start I see potential for growth in the chemical [indiscernible] and then question the first question was on an this year. Well, I say it is that strong. So it is kind of solid because there is any demand, but it's not huge. I mean there's no big impact, I would say, in many of these segments. I mean you only in part you see semiconductor but it is mainly driven by AI and also not so much on volume.

Tobias Ohler

executive
#22

Yes, more on the pricing side for polysilicon, maybe you picked we had a EUR 30 million one-off in the fourth quarter into make the run rate very cool that taking an for EUR 50 million from year from that on -- we said the scenarios, either risk solar for with our solar and improve our operations would improve from there. And what are the main drivers or drive is continue growth [indiscernible] believe that we can grow with the market not every year is the same, but we will grow over time with the market. The second is starting from follow-up operational dictionaries to a continue today, but and improve on fixed costs, which is so be better and the other thing we and foot test, I mean, we owe have to vest and we would not do on stream side that make an impressive I think that sort of gives you a well I mean yes, derive the confidence that we -- let's not be even this year -- but interesting and going forward, we can be better than today. And polysilicon as a segment with the consequence of to our ovation and into billing and then recently in this year, why we have -- I mean we have paid progress, and our chemicals are performing year. So -- if you look at the margins erode we want to have all the segments of the cargo, but we are going to talk about specific targets, but oil segment contribute to help margin a custom overall new part of and reach to 15% as mine point for I think some of you talked beforehand on the 15%, but minus 2% that it includes dollar doesn't include any -- it does include volatility either scenario.

Unknown Analyst

analyst
#23

[indiscernible] from Bank of America. I have 2 questions. One is, can you give more detail on the underlying assumptions on your margin target, so are to the lower end? What's the upper end? And then where is the biggest step-up coming from? Is it from nation leverage or poles or some mix? And then the second question side of solution. Is there any other areas where you invest in customer-facing roles or bringing in external people, for example, in silicons on growing the downstream part of that business. Do you have the right sales cars in place? Or is this also something where you bring in external people?

Christian Hartel

executive
#24

My thought was the first on the delivery segments Yes. But I mean all segments should contribute. And we should get into that corridor, our ambition with self-help. That's important with pace cost efficiency plus selective growth. And obviously, the larger segments contribute more because, I mean, if you look at the ad the group numbers, I mean their wages was tremendously important also the performance of silicones and polymers while I mean Bisolutions, obviously, we want to also bring into that corridor, but as total revenues are just shy of [indiscernible] sales. I mean their wage is not that big. Yes, your first question on the we have the right people and the mindset nothing we work both internally with programs like Leading and Wacker, which is a leadership program to train people, to get them better to have the right mindset and culture -- but yes, there is also an external addition of people. And that it depends a little bit on the different portfolio units, as I pointed out, I mean, for the accelerated growth, I mean you need to be a business hunter and at the moment, we are also in people internally and then thinking about who is the best use capabilities on which portfolio is it -- so you will see some shifts internally, but we will also go into the outside market, and that's what we also currently do to hire people that can act as a kind of as an initiator for changing also the culture because at the end of the day, people are the right way may it's about the people, but it's also about how we feel the business I think half of those portfolios, and we mentioned that we have -- in the last we have there. We have 4. We have some in time 4. So fundamentally, our complete steering model has been changed and become much more granular because in all 17 business units mentioned unit. And then you might pursue growth with actions. And those actions can monitor in a playbook that is put on a milestone plan -- so we are cascading throughout the organization, completely new steering where we match it's a bit of a measure tracking on the pump side with our KPIs that are for that portfolio business. So I mean, for the Acceleron obviously, it's about growth and margin. But for the Yes, maximizing returns. It's the ROCE. And for the other, it's a cash. So we have both help we feel the organization and the other, yes, and drives -- and I think that is a great labor. So the playbook that we have on pace, the label that we have on pricing. Also now the play house we run the portfolio unit. And it's -- yes, it is about people. I your question is absolutely valid. It's also about how we drive the organization. And it's a -- I mean, we -- I mean, it's a cultural change. because I would say in the past, there was more a broad-based look on growth opportunities kind everywhere, and everybody was kind of happy to see growth whereas now with these different portfolio units. If you are in maximize cash, you won't get a credit for growth itself. You get a credit for cash. If growth helps you to create more cash, fine. -- if growth dilutes your cash, you're on the wrong track. And that will be measured and communicated and it's [indiscernible] customers.

Unknown Analyst

analyst
#25

[indiscernible]So I want to talk about headwinds and tailwinds, a minute and compare silicons now to the good old days before COVID. I mean what changed? You have a lot more people have a lot more assets. Your revenues are up, but they're not up that much, but why your margins down so much? And how does that tie into what you're talking about today in terms of refocus on the culture and the things that you're looking for the way that you want to manage the people and the KPIs?

Christian Hartel

executive
#26

First of all, I had payer headwinds that the order -- we lost the same. I mean we still have a small portion of it, but we also have here 2017 and '18 where the markets were tight where we have earned a strong margin on that. And -- the same was true in '21 and '22 when markets were tight, and we earned the margin on that. We don't see that to come back, but you can only use the margin 1. We have lost that, and we don't think that overcapacity to change meaningful. We don't -- to be honest, we also don't focus much on the tension internally on that anymore. The silicon specialties, where we duplicated the specialties and even more tailored solutions, where really the growth driver going forward. And then we have invested as we have made out so we have soticapacities. And we have -- as I've talked about, we have had 17 portfolio units with a clear milestone plan. We have now a measure tracking for each unit where they should accelerate and where they should focus on return on cash. So our resource allocation will become no more granular. So we're not looking at certainly we have 4 business units and our business unit enter cloud to grow and they were fighting for resources and timing for CapEx. They don't get that in that sense anymore. That's why we have lower CapEx below depreciation, and we are much more selective. And now we are scaling the business and also the base, in particular, very much on is there an attractive market and do we have the ability to win here in that market. And only a strong pitch for that, we would accelerate as we would the focus and also lower and low sources on return -- can we still grow but improve the return by lowering resources or in the more extreme even yes, just focus on cash.

Tobias Ohler

executive
#27

And I would add that to your comment of the good over time, our clear statement to everybody in the company, they won't come back. They won't come back to good a time. So he needs to adapt and refocus was the answer to saying that in good old times, they go for everywhere in the market be get everywhere. It's just over. And we need to be much more selective -- and also, I would say that global competition also increased in recent years. You need. You need to be better, and we need to be more selective in order to achieve margins of the past. And the headcount increase is partly over addressed by PACE. So a big lever to lower the breakeven point in silicones, especially from the high fixed manufacturing cost is the PACE program. And I need to add that obviously, also for the downstream product or specialties, I mean, fixed costs are important. So if you are running on low utilization, you don't get the absorption. So growth is vital and we haven't seen much growth, I mean, on total over the last years, we had seen growth in focus areas, but we also lost business in some style market environments like construction. And we focus is now about self-help. We are focusing the growth being very improving the leverage from our -- and utilization from our assets and lower the cost to improve the breakeven point.

Unknown Analyst

analyst
#28

from Barclays. I just had a few questions on buying solutions. You've mentioned sort of filling the capacity Page has taken longer than expected. I wanted to ask if that's around the contract you had with the German government for EUR 80 million as I think the fit for EUR 200 million. Just is that the source of the issue and going forward, are you sensing that governments are still open to contracting going forward? And what is the sort of long-term intentionality with that business? And sort of also speaking currently with the modern date, have you seen any sort of immediate client uptick for appetite in the market?

Christian Hartel

executive
#29

On the biopharma business. And so part of that business is what we call the prep, the pandemic preparedness, tell the [indiscernible] government, the invested also in the brain facility is kind of on standby as of pandemic. There's ongoing contract and there are ongoing discussions also for longating of this contract [indiscernible] favor in this facility, and it's because the facility was built as 1 part is for the German government reserve. And the other part is kind of flexible for our use. [indiscernible] capacity, which could be utilized. We have 2 other sites out in Germany where we have the microbial fermentation for proteins. There we have a high utilization, we taste in Amsterdam and in the U.S., where there is still room for more projects. So we are ready for gaining more projects. But I think we have to say that in the RNA world, post COVID, part of the enthusiasm was gone especially regarding timing, I would not say regarding the opportunities because it's still huge, and I absolutely believe that takes longer time to be filled. And also keep in mind, I mean, biotech for example, significantly reduced capacities and closed sites after the pandemic because kind of they had too much of facilities. So we remain confident in that marketing. We take more efforts [indiscernible].

Unknown Analyst

analyst
#30

[indiscernible] from Citi again. And 2 follow-ups on Silicones, please. First 1 is to have this 20% plus margin target ambition. I just wondered whether that post all your pace measures and an improved mix, whether this is still a plausible scenario? Or would they really need the standard business to come back to get to those type of levels? And then second, also just a more difficult competitive landscape in silicones and in the 5% non-commodity business. How far down do you see that increased competition? In other words, how much of your business is genuinely protected by high entry barriers?

Christian Hartel

executive
#31

[indiscernible] not in specific segments and is but we don't rule it out. Of course, we know that depending on the portfolio and more than 20% of the silicon, but in a rich portfolio and there must not be a drag somewhere in your overall number. And that's why we are not specific on the segment ambition. But for sure, there is highly valuable effective segment any target. We have to standards, we make the best out of it. And as I mentioned, having a fully integrated supply chain has benefited, if it's relespecially on the midstream side. And over the time, we transfer more and more of these 15% remaining into downstream products. So with our targets. Now talking about the 85% downstream Solutions & Specialties you use a highly protected markets would be nice. But I would say, like in many other industries, today, very tough to talk about highly protected markets. You could argue maybe polysilicon for semi is one, but also in silicon, I mean, there is competition, obviously, and they are good competitors. So you just need to be faster and better and work on it every day. But these segments and products, which give you a very attractive market. And as we pointed out here in SL growth, if you talk about the Electronics segment, if you talk about the Automotive segment also, especially on vehicles. These are attractive segments also for us. But yes, they attract other [indiscernible]. And so therefore, -- also again, part of refocus put the resources where you see the biggest opportunities. So you put the biggest effort on innovation where you see the great potential for the company. Overall, I would say there's still a lot of opportunity silicones. I'm super convinced that is the best class or most versatile from the efficacy standpoint, and there will be also new applications coming up and you need to be faster in concert market. Well, maybe just 1 last question, and then we'll be here after the event. So if you have any additional questions, we can speak about over pain 1 last question.

Unknown Analyst

analyst
#32

Yes. Okay. And yes, thank you very much can pass over here.

Christian Hartel

executive
#33

Yes. Well, thank you, everybody, for joining our Ceradyne great pleasure presenting our new way forward with refocus for the next years with our financial ambitions. We appreciated the exchange on the Q&A slide and hopefully, we could enter most of it. And yes, it's keep in touch with Scott and Ger on the IR team, obviously, and we are looking forward for the next end calendar, which is later to the next call. Speak all on 29th, I think any problem. All right. Thank you very much for coming. Thank you.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Wacker Chemie AG transcript — plus 255,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Wacker Chemie AG earnings transcripts and 255,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.